title: Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.
authors.forename: Adam
authors.initials: A
authors.lastname: Lerner
authors.forename: Angela
authors.initials: A
authors.lastname: Beckford
authors.forename: Steve
authors.initials: S
authors.lastname: Ugent
authors.forename: Lynne
authors.initials: L
authors.lastname: Goldberg
authors.forename: Scharukh
authors.initials: S
authors.lastname: Jalisi
authors.forename: Marie-France
authors.initials: MF
authors.lastname: Demierre
mesh_terms: D018250:Acrospiroma / Q000188:drug therapy* / Q000473:pathology; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012074:Remission Induction; D012535:Scalp; D013544:Sweat Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil